Disease management
Researchers found that discovering progression to schizophrenia via machine learning based on routine clinical data is 'feasible.'
The announcement comes just three months after XRHealth announced it acquired cognitive training VR platform NeuroReality and its assets.
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The Australian-led project developed these maps, claimed to be the most detailed ever made, to link retinal thinning to various diseases.
Vik Bajaj, CEO of Foresite Labs and managing director of Foresite Capital, discusses how AI is used to develop personalized cancer vaccines - and the challenges and promises of Project Stargate.
Also, a new mobile app in Australia tracks eyelid movement to detect sleep apnoea.
The Sentinel Camera allows point-of-care retinal imaging and eliminates the need for a visit to an eye specialist's office.
The virtual opioid use disorder company reached profitability in Q4 2024, and expanded its team with the appointments of a chief operating officer and chief financial officer.
PanopticAI also claims to be the first in the city to obtain US FDA clearance for software as a medical device.
The company will use the funds to expand access to its hormonal healthcare platform across the U.S.